Navigation Links
Stuart Chesky, DO, JD, Ohio KePRO Medical Director, Appointed to Ohio Joint Legislative Study Commission on Most Favored Nation Clauses in Health Care Contracts

Dr. Chesky's medical and legal expertise will be critical when determining the impact of most favored nation clauses on health care costs and on the

availability of, and accessibility to, quality health care

HARRISBURG, Pa., Oct. 20 /PRNewswire/ -- Stuart Chesky, DO, JD, Medical Director of Ohio KePRO was one of 17 respected health care and legal experts chosen to serve on Ohio's Joint Legislative Study Commission on Most Favored Nation Clauses in Health Care Contracts. The Commission was established as part of HB-125, the Health Care Simplification Act, passed earlier this year.

"The overall goal of the Commission is to simplify the bureaucracy of the health care system so that hospitals and physicians can concentrate on what they do best -- caring for patients," said Dr. Chesky. "I am honored to have been selected to serve on the Commission that will focus on making health care contracting more fair for everyone. I will work hard for all Ohioans so that our health care delivery system is the best in the nation."

The Commission will study heath care contracts to investigate the precompetitive and anticompetitive aspects of favored nation clauses, which are contractual agreements between a buyer and a seller stating that the price paid by the buyer will be at least as low as the price paid by other buyers purchasing the same commodity -- in this case, health care.

The Commission will also address the impact that most favored nation clauses have on health care costs and on the availability of, and accessibility to, quality health care, and the costs associated with the enforcement of most favored nation clauses.

Dr. Chesky currently serves as Medical Director, where he oversees physician review services performed on behalf of Ohio's Medicare beneficiaries as part of the Ohio KePRO quality improvement organization (QIO) contract. He also is the medical director for the Health Resources & Services Administration (HRSA) contract held by parent company, KePRO, to provide expert medical malpractice review and risk management services on behalf of federally qualified health centers. In addition, Dr. Chesky is the Medical Director for KePRO's Florida Home Health contract and oversees KePRO's peer reviewer credentialing process.

Dr. Chesky received his Doctor of Osteopathic Medicine degree from Midwestern University/Chicago College of Osteopathic Medicine; his specialty is Obstetrical and Gynecological Surgery. He is licensed to practice medicine in multiple states, including Ohio. He received his Juris Doctorate degree from the Ohio Northern University College of Law. His Bachelor of Science degree is from Roosevelt University.

About Ohio KePRO

Ohio KePRO, a KePRO company, is the Medicare quality improvement organization (QIO) for the state of Ohio. Ohio KePRO, located in Cleveland, improves the quality of care for, and the quality of life of, Ohio's 1.8 million Medicare beneficiaries.

About KePRO

KePRO, a leading quality improvement and care management organization, offers innovative and outcomes-focused solutions to reduce the utilization of health care resources and optimize quality of care for public and commercial clients. KePRO's comprehensive, member centric care management solutions go far beyond traditional utilization and case management by coordinating the care provided to members with acute, chronic and complex conditions across the continuum, and identifying members who are at the highest risk for future services, but have not yet had an acute event. Tailored programs maximize members' quality of life, and realize greater cost savings for members and clients.

Headquartered in Pennsylvania, KePRO also has offices in Florida, Kentucky, Maryland, Ohio, Tennessee, and Virginia. KePRO is URAC health utilization management and case management accredited. For more information, visit

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors
2. KePRO Names Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director
3. Stuart Collins Joins OrthoSynetics(TM) as Director, Eastern Region Sales
4. KePROs Chief Medical Officer to Present and Participate in Physician Roundtable at McKesson Health Solutions Conference
5. Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director
6. KePROs Chief Medical Officer to Deliver Clinical Keynote Address
7. KePRO Appoints Two New IT Vice Presidents
8. Sharon McCudden Named KePRO Director of Business Process Improvement & Compliance
9. Concentric Medical Launches Distal Access Catheter
10. Varian Medical Systems Schedules Fiscal Year End Review in New York
11. Glycotex Finalizes Collaboration Agreement with Advanced Medical Solutions
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: